301 related articles for article (PubMed ID: 24583340)
1. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
Lohmann F; Sachs M; Meyer TN; Sievert H; Lindenmeyer MT; Wiech T; Cohen CD; Balabanov S; Stahl RA; Meyer-Schwesinger C
Biochim Biophys Acta; 2014 Jul; 1842(7):945-58. PubMed ID: 24583340
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.
Meyer-Schwesinger C; Meyer TN; Sievert H; Hoxha E; Sachs M; Klupp EM; Münster S; Balabanov S; Carrier L; Helmchen U; Thaiss F; Stahl RA
Am J Pathol; 2011 May; 178(5):2044-57. PubMed ID: 21514420
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
4. A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies.
Meyer-Schwesinger C; Meyer TN; Münster S; Klug P; Saleem M; Helmchen U; Stahl RA
J Pathol; 2009 Feb; 217(3):452-64. PubMed ID: 18985619
[TBL] [Abstract][Full Text] [Related]
5. NF-κB upregulates ubiquitin C-terminal hydrolase 1 in diseased podocytes in glomerulonephritis.
Zhang H; Mao X; Sun Y; Hu R; Luo W; Zhao Z; Chen Q; Zhang Z
Mol Med Rep; 2015 Aug; 12(2):2893-901. PubMed ID: 25976522
[TBL] [Abstract][Full Text] [Related]
6. UCH-L1 expression of podocytes in diseased glomeruli and in vitro.
Liu Y; Wu J; Wu H; Wang T; Gan H; Zhang X; Liu Y; Li R; Zhao Z; Chen Q; Guo M; Zhang Z
J Pathol; 2009 Apr; 217(5):642-53. PubMed ID: 19214988
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
Romero M; Ortega A; Izquierdo A; López-Luna P; Bosch RJ
Nephrol Dial Transplant; 2010 Aug; 25(8):2447-57. PubMed ID: 20200004
[TBL] [Abstract][Full Text] [Related]
8. Non-functional ubiquitin C-terminal hydrolase L1 drives podocyte injury through impairing proteasomes in autoimmune glomerulonephritis.
Reichelt J; Sachs W; Frömbling S; Fehlert J; Studencka-Turski M; Betz A; Loreth D; Blume L; Witt S; Pohl S; Brand J; Czesla M; Knop J; Florea BI; Zielinski S; Sachs M; Hoxha E; Hermans-Borgmeyer I; Zahner G; Wiech T; Krüger E; Meyer-Schwesinger C
Nat Commun; 2023 Apr; 14(1):2114. PubMed ID: 37055432
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-Catenin Signaling Mediated-UCH-L1 Expression in Podocytes of Diabetic Nephropathy.
Zhang H; Luo W; Sun Y; Qiao Y; Zhang L; Zhao Z; Lv S
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571062
[TBL] [Abstract][Full Text] [Related]
10. The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes.
Zhang H; Sun Y; Hu R; Luo W; Mao X; Zhao Z; Chen Q; Zhang Z
Cell Signal; 2013 Jul; 25(7):1574-85. PubMed ID: 23567262
[TBL] [Abstract][Full Text] [Related]
11. UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?
Cui JH; Xie X
Inflammation; 2017 Apr; 40(2):657-665. PubMed ID: 28116572
[TBL] [Abstract][Full Text] [Related]
12. Plakoglobin is involved in cytoskeletal rearrangement of podocytes under the regulation of UCH-L1.
Fang Y; Li F; Qi C; Mao X; Xu Y; Zhao Z; Wu H; Zhang Z
Biochem Biophys Res Commun; 2020 Aug; 529(1):112-118. PubMed ID: 32560811
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.
Rüster C; Bondeva T; Franke S; Förster M; Wolf G
Nephrol Dial Transplant; 2008 Jul; 23(7):2179-91. PubMed ID: 18344241
[TBL] [Abstract][Full Text] [Related]
14. Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress.
Hu Y; Qi C; Shi J; Tan W; Adiljan Abdurusul ; Zhao Z; Xu Y; Wu H; Zhang Z
Cell Mol Life Sci; 2023 Mar; 80(4):106. PubMed ID: 36952018
[TBL] [Abstract][Full Text] [Related]
15. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
[TBL] [Abstract][Full Text] [Related]
18. Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice.
Sun L; Zou LX; Han YC; Zhu DD; Chen T; Wang J
Clin Exp Nephrol; 2020 Feb; 24(2):107-118. PubMed ID: 31811410
[TBL] [Abstract][Full Text] [Related]
19. Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney.
Sawai K; Mukoyama M; Mori K; Kasahara M; Koshikawa M; Yokoi H; Yoshioka T; Ogawa Y; Sugawara A; Nishiyama H; Yamada S; Kuwahara T; Saleem MA; Shiota K; Ogawa O; Miyazato M; Kangawa K; Nakao K
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1363-72. PubMed ID: 17699553
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin C-terminal hydrolase L1 deletion ameliorates glomerular injury in mice with ACTN4-associated focal segmental glomerulosclerosis.
Read NC; Gutsol A; Holterman CE; Carter A; Coulombe J; Gray DA; Kennedy CR
Biochim Biophys Acta; 2014 Jul; 1842(7):1028-40. PubMed ID: 24662305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
